Cetuximab for esophageal cancer: an updated meta-analysis of randomized controlled trials

BACKGROUND: Increasing evidence indicates that cetuximab (CET) combined with chemoradiotherapy may be effective for patients with esophageal cancer. However, the recent results are still contradictory and no consensus has yet been reached on this issue. To evaluate the clinical effects and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ze-Hao, Ma, Xiao-Wen, Zhang, Jing, Li, Xiao, Lai, Na-Lin, Zhang, Sheng-Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258395/
https://www.ncbi.nlm.nih.gov/pubmed/30477458
http://dx.doi.org/10.1186/s12885-018-5040-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258395/
https://www.ncbi.nlm.nih.gov/pubmed/30477458
http://dx.doi.org/10.1186/s12885-018-5040-z

Ejemplares similares